Healthcare Sales & Marketing Network News: Pain Therapeutics

Searching News Database: Pain Therapeutics

HSMN NewsFeed - 6 Sep 2018
SiteOne Therapeutics Appoints John Hunter, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Mar 2017
Pain Therapeutics Announces Positive Regulatory Guidance for REMOXY(TM) ER
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 19 May 2016
Pain Therapeutics Announces FDA Advisory Committee Meeting for REMOXY(R)
Biopharmaceuticals FDA

HSMN NewsFeed - 29 Mar 2016
Pain Therapeutics Resubmits REMOXY New Drug Application to the U.S. Food and Drug Administration
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 23 Apr 2015
Pain Therapeutics Announces Appointment of Senior Vice President, Regulatory Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Apr 2015
Pain Therapeutics Resumes Responsibility for REMOXY
Biopharmaceuticals Licensing

HSMN NewsFeed - 26 Mar 2014
Xenon and Genentech Establish New Pain Discovery Collaboration
Biopharmaceuticals

HSMN NewsFeed - 13 Nov 2013
Novelos Therapeutics Announces a Restructuring of Its Board of Directors and Additional Changes to Its Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Oct 2013
Pfizer Proceeding with REMOXY(R) Development
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 7 Jan 2013
Celator(R) Pharmaceuticals Announces Appointment of Lisa DeLuca as Vice President, Regulatory Affairs
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 26 Nov 2012
Zogenix Appoints New Chief Commercial Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 24 Jul 2012
Infinity Announces New Addition to Senior Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Jan 2012
Endo Pharmaceuticals and BioDelivery Sciences International Sign Licensing Agreement for BEMA Buprenorphine
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 6 Jan 2012
BioDelivery Sciences Announces Worldwide License and Development Agreement with Endo Pharmaceuticals for BEMA Buprenorphine
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 27 Jan 2011
REMOXY New Drug Application Accepted by FDA
Biopharmaceuticals Pain Management

HSMN NewsFeed - 1 Sep 2010
Archimedes Pharma Receives European Marketing Authorisation for PecFent(R) for the Treatment of Breakthrough Cancer Pain
Biopharmaceuticals Regulatory

HSMN NewsFeed - 23 Aug 2010
Archimedes Pharma US Announces New US Headquarters In Bedminster, New Jersey
Biopharmaceuticals

HSMN NewsFeed - 29 Jun 2010
King Pharmaceuticals Amends Strategic Alliance for REMOXY(R) in Europe
Biopharmaceuticals

HSMN NewsFeed - 5 Aug 2009
Anesiva, Inc. and Arcion Therapeutics Announce Merger Agreement
Biopharmaceuticals Mergers & Acquisitions Personnel

HSMN NewsFeed - 19 Aug 2008
Pain Therapeutics and King Pharmaceuticals Announce Final Data of REMOXY Phase III Study at World Pain Congress in Scotland
Biopharmaceuticals

HSMN NewsFeed - 10 Jun 2008
Pain Therapeutics and King Pharmaceuticals Announce Submission of New Drug Application for Remoxy
Biopharmaceuticals

HSMN NewsFeed - 28 Apr 2008
Labopharm Appoints Dr. Claire Brull� as Senior Vice-President and Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Dec 2007
Remoxy Meets Primary Endpoint in Pivotal Phase III Study
Biopharmaceuticals

HSMN NewsFeed - 31 Oct 2007
King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acura's Aversion(R) (Abuse-Deterrent) Technology
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 20 Aug 2007
NeurAxon Announces $32 Million Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 7 Aug 2007
NeurAxon Appoints Robert Medve, M.D., as Chief Medical and Regulatory Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Jul 2007
Patient Recruitment Completed for Pivotal Phase III Study of Remoxy
Biopharmaceuticals Pain Management

HSMN NewsFeed - 22 Mar 2007
Pain Therapeutics Licenses Biotechnology To Treat Rare Disorder
Biopharmaceuticals Licensing

HSMN NewsFeed - 6 Mar 2007
PainCeptor Pharma Raises $24.4 M Series B Investment Round
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 26 Feb 2007
King Pharmaceuticals Completes Strategic Acquisition of AVINZA(R)
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 3 Jan 2007
Victory Pharma, Inc. Signs NAPRELAN(R) Agreement; US Field Sales Force to Expand
Biopharmaceuticals Distribution

HSMN NewsFeed - 13 Dec 2006
Pain Therapeutics Initiates Phase III Study With Oxytrex(TM)
Biopharmaceuticals

HSMN NewsFeed - 7 Sep 2006
King Pharmaceuticals Announces Strategic Acquisition of Avinza(R) from Ligand Pharmaceuticals
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 6 Jun 2006
Corgentech Announces Appointment of K. Peony Yu as Vice President, Clinical Research and Michael Leong as Director, Clinical Research
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 May 2006
ORADUR(TM) Technology Milestone: Remoxy(TM) (ORADUR-Based Oxycodone) Commences Pivotal Phase III Program
Biopharmaceuticals

HSMN NewsFeed - 22 Feb 2006
Kosan Expands Executive Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Feb 2006
ORADUR(TM) Technology Milestone: Remoxy(TM) (ORADUR-based oxycodone) Receives Special Protocol Assessment and Commences Pivotal Phase III
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 16 Feb 2006
Pain Therapeutics and King Pharmaceuticals Receive Special Protocol Assessment for Remoxy(TM) and Commence Pivotal Phase III
Biopharmaceuticals

Return to NewsFeed

Additional items found! 26

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 26 additional stories matching:
Pain Therapeutics
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.